A2i Therapeutics secures seed funding from FutuRx and its investors - Johnson & Johnson Innovation (JJDC, Inc.), Takeda Ventures, OrbiMed Partners, Leaps by Bayer and the Israeli Innovation Authority ...

Israel's FutuRx, US-based Atomwise enter into strategic partnership The A2i Therapeutivs joint venture project will be funded by the Israeli Innovation Authority, FutuRx investors and addition ...

432HZ, the Argentine music label and company with areas devoted to leadership, music marketing and promotion and education, is launching its monthly FUTURX event. By Billboard Staff 432HZ, the ...

It may contain inaccuracies due to the limitations of machine translation. The process of cancer treatment through TNIK inhibition. Courtesy of the Korea Research Institute of Chemical Technology. The ...

At FutuRx, Johnson & Johnson Innovation, Takeda Ventures Inc. and OrbiMed teamed with the Office of the Chief Scientist of the Ministry of Economy in a national initiative dedicated to transforming ...

Standing on a modestly sized black box stage, the Ciudad Juárez-born poet Jesús Valles muses on lost loves, juvenescence on both sides of the border, and the shooting this year that left 22 El Pasoans ...

NESS-ZIONA, Israel, Jan. 12, 2020 /PRNewswire-PRWeb/ -- FutuRx, Israel's leading biopharmaceutical incubator, a partnership of OrbiMed Israel Partners, Johnson & Johnson Innovation - JJDC, and Takeda ...

After raising $123 million this past summer to fuel its artificial-intelligence-based drug design work, Atomwise has helped launch a new company focused on uncovering treatments in immuno-oncology.

FuturX is a five-day festival that celebrates the many permutations and intersections of LatinX identity in the 21st Century and beyond, featuring the works from playwrights, solo performers, and ...

A2i Therapeutics secures seed funding from FutuRx and its investors Johnson Johnson Innovation (JJDC, Inc.), Takeda Ventures, OrbiMed Partners, Leaps by Bayer and the Israeli Innovation Authority to ...